ATE274915T1 - Oregano zur behandlung interner parasiten und protozoen - Google Patents

Oregano zur behandlung interner parasiten und protozoen

Info

Publication number
ATE274915T1
ATE274915T1 AT99927540T AT99927540T ATE274915T1 AT E274915 T1 ATE274915 T1 AT E274915T1 AT 99927540 T AT99927540 T AT 99927540T AT 99927540 T AT99927540 T AT 99927540T AT E274915 T1 ATE274915 T1 AT E274915T1
Authority
AT
Austria
Prior art keywords
oregano
treatment
protozoa
internal parasites
parasites
Prior art date
Application number
AT99927540T
Other languages
English (en)
Inventor
Daryl L Deluca
William S Sparks
Robert A Ronzio
Denis R Deluca
Original Assignee
Biotics Res Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotics Res Corp filed Critical Biotics Res Corp
Application granted granted Critical
Publication of ATE274915T1 publication Critical patent/ATE274915T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT99927540T 1998-06-18 1999-06-16 Oregano zur behandlung interner parasiten und protozoen ATE274915T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/099,580 US5955086A (en) 1998-06-18 1998-06-18 Oregano for the treatment of internal parasites and protozoa
PCT/US1999/013497 WO1999065505A1 (en) 1998-06-18 1999-06-16 Oregano for the treatment of internal parasites and protozoa

Publications (1)

Publication Number Publication Date
ATE274915T1 true ATE274915T1 (de) 2004-09-15

Family

ID=22275684

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99927540T ATE274915T1 (de) 1998-06-18 1999-06-16 Oregano zur behandlung interner parasiten und protozoen

Country Status (10)

Country Link
US (1) US5955086A (de)
EP (1) EP1089745B1 (de)
JP (1) JP4558200B2 (de)
AT (1) ATE274915T1 (de)
AU (1) AU741087B2 (de)
CA (1) CA2335485C (de)
DE (1) DE69919868T2 (de)
ES (1) ES2228057T3 (de)
MX (1) MXPA00012685A (de)
WO (1) WO1999065505A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6342249B1 (en) 1998-12-23 2002-01-29 Alza Corporation Controlled release liquid active agent formulation dosage forms
KR100618234B1 (ko) * 1998-12-23 2006-09-01 알자 코포레이션 다공성 입자를 포함하는 제형
US6414036B1 (en) 1999-09-01 2002-07-02 Van Beek Global/Ninkov Llc Composition for treatment of infections of humans and animals
US6579542B1 (en) * 2000-03-02 2003-06-17 Cecil Faulkner Treating feline-specific disorders by orally administering Hydrastis canadensis
WO2002058469A1 (en) * 2001-01-23 2002-08-01 Van Beek, Ron Pesticidal compounds and compositions
US6884763B2 (en) 2001-10-30 2005-04-26 Permatex, Inc. Waterless hand cleaner containing plant derived natural essential oil
EP1480527A4 (de) * 2002-02-13 2005-03-30 Beek Global Ninkov L L C Van Zusammensetzungen und verfahren zur erhöhung der milchproduktion bei tieren
US7144590B2 (en) * 2003-01-09 2006-12-05 Lipoprotein Technologies, Inc. Bioactive compositions derived from humulus lupulus
WO2005085287A1 (en) * 2004-03-03 2005-09-15 En-N-Tech, Inc. Treatments for contaminant reduction in lactoferrin preparations and lactoferrin-containing compositions
US8992999B2 (en) 2004-06-25 2015-03-31 Alltech, Inc. Methods and compositions for controlling parasitic infections of animals
ATE460081T1 (de) * 2004-07-21 2010-03-15 Alltech Inc Zusammensetzung und ihre verwendung zur bekämpfung von protozoen-infektionen von tieren
US8119169B2 (en) 2004-12-28 2012-02-21 Colgate-Palmolive Company Oregano oral care compositions and methods of use thereof
US20080032021A1 (en) * 2006-05-19 2008-02-07 Faltys Gary L Feed supplements for ruminants including essential oil compounds and organic acids
US20090226549A1 (en) 2008-03-06 2009-09-10 Kenneth John Hughes Herbal extracts and flavor systems for oral products and methods of making the same
US20110059205A1 (en) * 2009-09-04 2011-03-10 Sylvia Gaysinsky Botanical extracts and flavor systems and methods of making and using the same
US20130101634A1 (en) * 2011-10-12 2013-04-25 Deerland Enzymes, Inc. Compositions and methods for reducing microbial overgrowth in the small intestines
GB201404505D0 (en) * 2013-09-06 2014-04-30 Mars Inc Oral anti-parasitic composition
US9913478B2 (en) * 2013-12-02 2018-03-13 Arrowhead Center, Inc. Organic and environmentally “green” biocide compositions and applications
JP6372158B2 (ja) * 2014-05-15 2018-08-15 住友ベークライト株式会社 食品包装用シート、食品包装容器および食品包装体
GR20180100568A (el) * 2018-12-27 2020-07-16 Μαριανα Γεωργιου Χατζαρα Συνθεση με βαση το δικταμο κατα του βακτηριου ακανθαμοεμπα που προσβαλλει τους οφθαλμους

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9608841A (pt) * 1995-05-26 1999-12-07 Ropapharm B V Composição farmacêutica,uso da composição,e processo para recuperar óleo de plantas
GR1002451B (el) * 1995-06-29 1996-10-14 ������ �. Αντιφλεγμονωδεις συνθεσεις που εχουν ως βαση ενεργα συστατικα ορισμενων βοτανων χρησιμοποιουμενες για σκοπους ιατρικους και κτηνιατρικους, και μεθοδοι παρασκευης φαρμακων και σκευασματων για τους παραπανω σκοπους.

Also Published As

Publication number Publication date
DE69919868D1 (de) 2004-10-07
AU741087B2 (en) 2001-11-22
JP4558200B2 (ja) 2010-10-06
WO1999065505A1 (en) 1999-12-23
JP2002518338A (ja) 2002-06-25
CA2335485C (en) 2008-12-02
EP1089745A1 (de) 2001-04-11
ES2228057T3 (es) 2005-04-01
EP1089745B1 (de) 2004-09-01
MXPA00012685A (es) 2003-09-10
US5955086A (en) 1999-09-21
AU4442099A (en) 2000-01-05
CA2335485A1 (en) 1999-12-23
DE69919868T2 (de) 2005-08-25
EP1089745A4 (de) 2002-03-20

Similar Documents

Publication Publication Date Title
ATE274915T1 (de) Oregano zur behandlung interner parasiten und protozoen
ATE340171T1 (de) Piperazinderivate zur behandlung bakterieller infektionen
DE60117896D1 (de) Verfahrensschema zur Behandlung von Diesel und Vakuumgasöl
DE69929041D1 (de) Verwendung von cabergolin zur behandlung von "restless legs syndrom"
ATE247117T1 (de) Pyrazolopyrimidinone cgmp pde5 inhibitoren zur behandlung von sexualfunktionsstörungen
ATE350364T1 (de) Adamantanderivate zur behandlung von entzündlichen, immunologischen und kardiovaskulären erkrankungen
DE69922688D1 (de) Zusammensetzungen aus einem 5ht1b/1d agonisten und einem selektiven cox-2 hemmer zur behandlung von migräne
DE60045386D1 (de) Gerät zur thermischen behandlung von bandscheiben
ATE451921T1 (de) Phenylindole zur behandlung von hiv
ATE448775T1 (de) Rifalazil zur behandlung von infektionen mit clostridium difficile
ATE255894T1 (de) Mglur5 antagonisten zur behandlung von schmerzen und angstzuständen
DE60208186D1 (de) Chinazolin- und chinazolinähnliche verbindungen zur behandlung von integrinvermittelten erkrankungen
DE60136477D1 (de) Retinoide zur behandlung von emphysem
DE69928779D1 (de) Nichtnukleoside reverse transkriptase-hemmer zur behandlung von hiv-infektion
DE60139783D1 (de) Gen und pflanzenextrakte, wirksam zur behandlung und prävention von chlamydieninfektionen
DE60219658D1 (de) Verfahren zur prävention und behandlung von infektionen mit dem flavivirus bei tieren
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
ATE347888T1 (de) Verwendung von aivlosin zur behandlung und prevention der lawsonia-infektionen in schweinen.
ATE273276T1 (de) Cyclobutendion-derivate zur behandlung von artherosclerose
PT1274426E (pt) Uso de tioamida-oxazolidinonas no tratamento da reabsorcao ossea e da osteoporose
DE69840649D1 (de) Hydrophile zusammensetzung, die eine von vibrio proteolyticus hergestellte protease enthält
DE60103685D1 (de) Behandlung von Poriomania
SE0302361D0 (sv) Inhibering av upptagning av monoamin
NO20005548D0 (no) Mykobakterieinhibitorer
DE60109594D1 (de) R-eliprodil zur behandlung von glaucoma

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties